Heidenhain variant of Creutzfeldt-Jakob disease: Diffusion-weighted MRI and PET characteristics

被引:20
作者
Tsuji, Y
Kanamori, H
Murakami, G
Yokode, M
Mezaki, T
Doh-ura, K
Taniguchi, K
Matsubayashi, K
Fukuyama, H
Kita, T
Tanaka, M
机构
[1] Kyoto Univ, Dept Geriatr Med, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Dept Neurol, Grad Sch Med, Kyoto 6068507, Japan
[3] Kyoto Univ, Dept Funct Brain Imaging, Grad Sch Med, Human Brain Res Ctr, Kyoto 6068507, Japan
[4] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan
[5] Kyoto Univ, Translat Res Ctr, Fac Med, Kyoto 6068507, Japan
[6] Kyushu Univ, Dept Neuropathol, Neurol Inst, Fukuoka 812, Japan
[7] Kyoto Univ, Ctr SE Asian Studies, Kyoto 6068507, Japan
关键词
Creutzteldt-Jakob disease; visual disturbance; 14-3-3; protein; diffusion-weighted MRI; PET; visual evoked potentials;
D O I
10.1177/1051228403258147
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Creutzfeldt-Jakob disease (CJD) is characterized by rapidly progressive dementia with a variety of neurological disorders and a fatal outcome. The authors present a case with visual disturbance as a leading symptom and rapid deterioration in global cognitive functions. The cerebrospinal fluid was positive for 14-3-3 protein, and diffusion-weighted magnetic resonance imaging (MRI) showed marked hyperintensity in the parieto-occipital cortices, where hypometabolism was clearly detected on positron emission tomography (PET). Pattern -reversal visual evoked potentials showed prolonged P100 latencies and increased N75/P100 amplitudes. All these findings supported a diagnosis of the Heidenhain variant of CJD, whereas a long clinical course, a lack of myoclonus, and an absence of periodic synchronous discharges on electroencephalography were atypical. Diffusion-weighted MRI and PET in combination with visual evoked potential recording and 14-3-3 protein detection may be useful for the early diagnosis of CJD.
引用
收藏
页码:63 / 66
页数:4
相关论文
共 27 条
  • [1] SENSORY EVOKED-POTENTIALS IN CREUTZFELDT-JAKOB DISEASE
    AGUGLIA, U
    FARNARIER, G
    REGIS, H
    OLIVERI, RL
    QUATTRONE, A
    [J]. EUROPEAN NEUROLOGY, 1990, 30 (03) : 157 - 161
  • [2] Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease
    Bahn, MM
    Parchi, P
    [J]. ARCHIVES OF NEUROLOGY, 1999, 56 (05) : 577 - 583
  • [3] Diagnosis of Creutzfeldt-Jakob disease -: Effect of clinical criteria on incidence estimates
    Brandel, JP
    Delasnerie-Lauprêtre, N
    Laplanche, JL
    Hauw, JJ
    Alpérovitch, A
    [J]. NEUROLOGY, 2000, 54 (05) : 1095 - 1099
  • [4] Creutzfeldt-Jakob disease -: Neurophysiologic visual impairments
    de Seze, J
    Hache, JC
    Vermersch, P
    Arndt, CF
    Maurage, CA
    Pasquier, F
    Laplanche, JL
    Ruchoux, MM
    Leys, D
    Destée, A
    Petit, H
    [J]. NEUROLOGY, 1998, 51 (04) : 962 - 967
  • [5] Diffusion-weighted MRI in sporadic Creutzfeldt-Jakob disease
    Demaerel, P
    Heiner, L
    Robberecht, W
    Sciot, R
    Wilms, G
    [J]. NEUROLOGY, 1999, 52 (01) : 205 - 208
  • [6] Eschweiler GW, 2002, NERVENARZT, V73, P883, DOI 10.1007/s00115-002-1360-x
  • [7] MR imaging of Creutzfeldt-Jakob disease
    Finkenstaedt, M
    Szudra, A
    Zerr, I
    Poser, S
    Hise, JH
    Stoebner, JM
    Weber, T
    [J]. RADIOLOGY, 1996, 199 (03) : 793 - 798
  • [8] Giant visually-evoked potentials without myoclonus in the Heidenhain type of Creutzfeld-Jakob disease
    Finsterer, J
    Bancher, C
    Mamoli, B
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 167 (01) : 73 - 75
  • [9] Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease
    Green, AJE
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 : 382 - 386
  • [10] Grunwald F, 1996, Ann Nucl Med, V10, P131